Pharmaceutisch Weekblad

, Volume 5, Issue 1, pp 1–8 | Cite as

Clinical trial under trial

Trial and error
  • W. M. Rosinga
Review Articles


Randomized controlled clinical trials are being exposed to severe criticism in recent years. It is questioned if the use of placebos in such trials is ethically justified. This and other ethical problems will be discussed in this paper. Ethical problems include, besides the use of placebos. obtainment of informed consent and the belief in ‘treatment indifference’. Beforehand a historical overview is presented and the design of the randomized controlled clinical trial is explained. Some other types of clinical trials will also be touched upon.


Public Health Placebo Clinical Trial Internal Medicine Control Clinical Trial 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Brahams, D. (1982)Lancet I, 1028–1029;Ibidem (1982)II, 275.Google Scholar
  2. Burkhardt, R., andG. Kienle (1978)Lancet II, 1356–1359;Ibidem (1981)Eur. J. Clin. Pharmacol. 20, 311–319.Google Scholar
  3. Bywater, C.L. (1982)Lancet I, 1189.Google Scholar
  4. Chalmers, T.C., J.B. Block andS. Lee (1972)N. Engl. J. Med. 287, 75–78.Google Scholar
  5. Chalmers, T.C. (1974)Mt Sinai J. Med. 41, 753–759.Google Scholar
  6. Clayton, D.G. (1982)Br. J. Clin. Pharmacol. 13, 469–480.Google Scholar
  7. Declaration of Helsinki (as revised Tokyo, 1975) 18th World Medical Assembly (1964).Google Scholar
  8. Ditchley Report: Report Conference Ditchley Foundations (1979)Eur. J. Clin. Pharmacol. 18, 129–134.Google Scholar
  9. Editorial (1979)Lancet I, 534–535.Google Scholar
  10. Editorial (1982)Lancet II, 78–79.Google Scholar
  11. Editorial (1981)JAMA 246, 2481–2482.Google Scholar
  12. Elkeles, A. (1982)Lancet I, 1189.Google Scholar
  13. Fincke, M. (1977)Arzneimittelprüfung: strafbare Versuchsmethoden. C.F. Müller Juristischer Verlag, Heidelberg-Karlsruhe.Google Scholar
  14. Forbes, J.F. (1981)Med. J. Aust. 1, 159–160.Google Scholar
  15. Friedman, L.M., C.D. Furberg andD.L. Demets (1982)Fundamentals of clinical trials, 2nd ed. John Wright, PSG Inc. Boston-Briston-London.Google Scholar
  16. Hayden, G.F., M.S. Kramer andR.I. Horwitz (1982)JAMA 247, 326–331.Google Scholar
  17. Hill, A.B. (1963)Br. Med. J. 1, 1043–1049.Google Scholar
  18. Horwitz, R.I., andA.R. Feinstein (1981)JAMA 246, 2455–2459.Google Scholar
  19. Howard, J., andL. Friedman (1981)Clin. Pharmacol. Ther. 29, 561–569.Google Scholar
  20. Jesdinsky, H.J. (1981)Eur. J. Clin. Pharmacol. 20, 235–236.Google Scholar
  21. Joyce, C.R.B. (1982)Br. J. Clin. Pharmacol. 13, 313–318.Google Scholar
  22. Lindeboom, G.A. (1961)Inleiding tot de geschiedenis der geneeskunde. Erven F. Bohn NV, Haarlem.Google Scholar
  23. Machin, D., andW.E. Waters (1982)Lancet II, 275–276.Google Scholar
  24. Meinertz, Th. (1982)Deutsche Apotheker Zeitung 122, 742–745Google Scholar
  25. Rose, G. (1982)Br. J. Clin. Pharmacol. 13, 157–162.Google Scholar
  26. Sacks, H., T.C. Chalmers andH. Smith (1982)Am. J. Med. 72, 233–240.Google Scholar
  27. Shaw, L.W., andT.C. Chalmers (1970)Ann. N.Y. Acad. Sci. 169, 487.Google Scholar
  28. Simmons, B. (1978)J. Med. Ethics 4, 172.Google Scholar
  29. Spodick, D.H. (1982)JAMA 247, 2258–2260.Google Scholar
  30. Von Essen, C.F. (1982)Lancet I, 1189.Google Scholar
  31. Wade, O.L. (1982)Lancet II, 275.Google Scholar
  32. Weatherall, D.J. (1982)J. Med. Ethics 8, 63–64.Google Scholar
  33. Weinstein, M.C. (1974)N. Engl. J. Med. 291. 1278–1285.Google Scholar

Additional references

  1. Schafer, A. (1982)N. Engl. J. Med. 307, 719–724.Google Scholar
  2. Vere, D. (1981)J. R. Soc. Med. 74, 85–87.Google Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1983

Authors and Affiliations

  • W. M. Rosinga
    • 1
  1. 1.BergwegziekenhuisCB RotterdamThe Netherlands

Personalised recommendations